Flputnam Investment Management Co. Acquires 10,799 Shares of Astera Labs, Inc. $ALAB

Flputnam Investment Management Co. grew its holdings in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 116.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 20,063 shares of the company’s stock after buying an additional 10,799 shares during the quarter. Flputnam Investment Management Co.’s holdings in Astera Labs were worth $3,338,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of ALAB. Vanguard Group Inc. raised its position in shares of Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after purchasing an additional 1,693,918 shares during the period. Amundi increased its holdings in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the period. Rafferty Asset Management LLC bought a new stake in Astera Labs during the 3rd quarter worth approximately $209,599,000. BNP Paribas Financial Markets increased its holdings in Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after acquiring an additional 960,899 shares during the period. Finally, Voloridge Investment Management LLC bought a new stake in Astera Labs during the 3rd quarter worth approximately $131,539,000. Institutional investors own 60.47% of the company’s stock.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. The trade was a 7.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,316,257 shares of company stock valued at $474,860,636 in the last quarter. Corporate insiders own 12.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ALAB. Jefferies Financial Group reaffirmed a “buy” rating and set a $270.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Evercore reaffirmed an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. Stifel Nicolaus upped their target price on shares of Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Royal Bank Of Canada upped their target price on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, May 6th. Finally, Roth Mkm reaffirmed a “buy” rating and set a $275.00 target price on shares of Astera Labs in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Check Out Our Latest Research Report on Astera Labs

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Astera Labs announced it will host press conferences, live demos, and technical talks at Computex 2026, where it plans to showcase its AI connectivity portfolio, including the Scorpio X-Series 320 Lane Smart Fabric Switch, optical connectivity, and COSMOS-enabled validation tools. The event should help support visibility with analysts, customers, and ecosystem partners. Article Title
  • Positive Sentiment: The company’s recent conference presentation at TD Cowen and broader analyst attention keep the focus on Astera Labs’ AI infrastructure growth story and product roadmap. Article Title
  • Neutral Sentiment: Northland Securities downgraded ALAB from outperform to market perform, which may cap some near-term enthusiasm but does not signal a major change in the company’s fundamentals.
  • Negative Sentiment: Insider selling remains a notable overhang, including COO Sanjay Gajendra’s large prearranged sale of 400,000 shares and General Counsel Philip Mazzara’s sale of 796 shares. Even though these trades were disclosed and one was made under a 10b5-1 plan, heavy insider selling can weigh on investor sentiment. Article Title

Astera Labs Price Performance

ALAB stock opened at $325.33 on Thursday. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $326.97. The stock has a market cap of $55.76 billion, a PE ratio of 219.82, a P/E/G ratio of 4.22 and a beta of 3.35. The firm has a 50 day simple moving average of $182.05 and a two-hundred day simple moving average of $162.57.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the previous year, the company earned $0.33 EPS. The business’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.